- 米国企業
- Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc.INDP
| 2021年
12月31日 | 2022年
12月31日 |
|---|
| Net loss | -7,711,386 | -14,322,798 |
|---|
| Depreciation | 1,403 | 1,781 |
|---|
| Stock-based compensation | 2 | 3 |
|---|
| Realized gain on assets held for sale | - | 24,155 |
|---|
| Realized gain on marketable securities | - | 110,002 |
|---|
| Prepaid expenses and other current assets | 837,917 | -295,220 |
|---|
| Accounts payable and other current liabilities | -4,236,656 | -1,154,829 |
|---|
| Other assets | 16,477 | 721,774 |
|---|
| Operating lease right-of-use asset and liability, net | 240 | 961 |
|---|
| Net cash used in operating activities | -11,290,535 | -13,078,347 |
|---|
| Proceeds received for assets held for sale | 451,600 | 172,555 |
|---|
| Purchases of property and equipment | 3,854 | - |
|---|
| Purchase of marketable securities | - | 30 |
|---|
| Maturity of marketable securities | - | 13 |
|---|
| Net cash (used in) provided by investing activities | 447,746 | -16,427,018 |
|---|
| Proceeds from merger | 16 | - |
|---|
| Decoy's transaction costs | 665,627 | - |
|---|
| Issuance of pre-funded warrants and warrants | 30 | - |
|---|
| Issuance costs of Private Placement | 3 | - |
|---|
| Exercise of pre-funded warrants | 27,273 | - |
|---|
| Proceeds from SAFEs, net | 5 | - |
|---|
| Exercise of stock options | 363,058 | - |
|---|
| Net cash provided by financing activities | 48 | - |
|---|
| Net (decrease) increase in cash and cash equivalents | 37 | -29,505,365 |
|---|
| Conversion of preferred stock | 8,359 | - |
|---|
| Conversion of SAFEs | 6 | - |
|---|
| Initial recognition of operating right-of-use asset and lease liability upon lease commencement | 183,480 | - |
|---|
| Reclass from non-current assets to current assets | 44,445 | - |
|---|
| Release of deposit upon closing of merger | 200,000 | - |
|---|
| Issuance of initial commitment shares | - | 1,425 |
|---|
| Change in unrealized gain on marketable securities | - | 96,434 |
|---|
| Cash paid for income taxes | - | 2,400 |
|---|
| Cash received for interest earned on deposits | 5,141 | 111,018 |
|---|